Efficient Ultrafiltration/Diafiltration Process Development
Inline Particle Monitoring in Downstream mAb Purification
Sekilas Program
- Background of generic downstream process flow and UFDF process development
- Improving development efficiency
- Inline monitoring of particulate formation
This presentation reviews GSK's work with in-situ particle monitoring for efficient ultrafiltration/diafiltration process development in downstream processing of monoclonal antibodies (mAbs). Discover how GSK is using this innovative technology to streamline the production of mAbs and improve the overall efficiency of their downstream processing.
During this webinar, our expert speaker will share insights into the challenges faced in mAbs downstream processing and how in-situ particle monitoring can help overcome these challenges. You'll learn about the various applications of this technology, and how it is being used to monitor and control particle size and shape during ultrafiltration and diafiltration.
This is a must-attend event for anyone working in the field of mAbs production and downstream processing, or for anyone interested in learning about the latest advancements in this area. Register today and discover how in-situ particle monitoring can help you achieve a more efficient and effective mAbs production process.
